Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology

Academic, industry, regulatory leaders and patient advocates in cancer clinical research met in November 2018 at the Innovation and Biomarkers in Cancer Drug Development meeting in Brussels to address the existing dichotomy between increasing calls for personalised oncology approaches based on indiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2019-06, Vol.114, p.128-136
Hauptverfasser:	Salgado, Roberto, Solit, David B., Rimm, David L., Bogaerts, Jan, Canetta, Renzo, Lively, Tracy, Lyerly, Kim, Span, Paul N., Bateman-House, Alison, Makady, Amr, Bergmann, L., Nagai, Sumimasa, Smith, Chris, Robson, Mark, Savage, Mary, Voest, Emile, Sweeney, Christopher, Lambin, Philippe, Thomas, Marlene, Harris, Lyndsay, Lacombe, Denis, Massard, Chistophe, Bernards, Rene, Sullivan, Richard, Tejpar, Sabine, Lukinova, Nina, Lyerly, Herbert K., Moore, Helen, Smith, Malcolm A., Yee, Laura, DuBois, Ray, Hahn, William C., Janne, Pasi, Willman, Cheryl L., Rimm, David, Bergmann, Lothar, Cree, Ian A., Hegde, Priti, Hopper, Shirley, Robson, Marc, Ingelman-Sundberg, Magnus, Nichols, Gwen, Maignen, Francois, Besse, Benjamin, Swierzewski, Rafal, Kiermaier, Astrid, Massard, Christophe, Caliguri, Michael, Velculescu, Victor, Foggi, Paolo, Hahn, Willem C., Golfinopoulos, Vassilis
Format:	Artikel
Sprache:	eng
Schlagworte:	Autonomy Biomarkers Cancer Clinical trials Deoxyribonucleic acid DNA Drug development Evidence-driven optimal health-care delivery Health technology assessment Humans Medical Oncology - methods Medical research Molecular and immunologic profiling New technology Oncology Precision Medicine Therapeutic applications Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!